Redeye remains neutral to Formpipe following a strong Q1 with few forward-looking implications – high Deliveries and solid cost control. We believe that Formpipe will experience only a minor impact from the Corona crisis. However, the share is trading close to an all-time high. We leave our Base case and forecasts largely unchanged.